Lincoln University, PA, United States of America

Amy Tyler

This inventor holds 1 USPTO granted patent. Top assignee: Siemens Healthcare Diagnostics Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amy Tyler. Retrieved from https://idiyas.com/inventor/amy-tyler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amy Tyler: Inventor in Immunoassay Diagnostics

Introduction

Amy Tyler is an inventor associated with Lincoln University, Pennsylvania, and Siemens Healthcare Diagnostics GmbH. Her patent work concerns identifying aberrant immunoassay results that may arise when delivery of a polyhapten reagent is incomplete.

Latest Patents

Tyler is credited with 1 patent: “Methods for Detecting Aberrant Results Caused by Incomplete Delivery of a Polyhapten Reagent in Immunoassays.” The invention describes methods for detecting unusual results linked to delivery issues involving a polyhapten reagent in immunoassays.

Career Highlights

A key highlight of Tyler’s listed inventive work is her contribution to methods addressing reagent-delivery problems in immunoassay testing. Her patent connects her work with diagnostic technologies at Siemens Healthcare Diagnostics GmbH.

Collaborations

The available information associates Tyler’s patent with Siemens Healthcare Diagnostics GmbH. No additional collaborators are identified in the provided details.

Conclusion

Amy Tyler’s patent focuses on detecting immunoassay results that may be affected by incomplete polyhapten reagent delivery, reflecting her contribution to diagnostic testing methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…